Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Denis S. Kutilin"'
Publikováno v:
Kazan medical journal. 103:725-736
Background. The problem of lymph nodes metastases diagnosing in cervical cancer remains relevant and not fully resolved. The last decade studies results have shown the great potential of molecular markers in lymph nodes metastasis prediction, however
Publikováno v:
Bulletin of Experimental Biology and Medicine. 170:332-339
We analyzed the peculiarities of the copy number variation of genes that regulate apoptosis, DNA repair, cell proliferation, metabolism, and estrogen reception in tumor and normal cells of high-grade and low-grade serous adenocarcinoma of the ovaries
Publikováno v:
Онкогинекология. :35-49
Autor:
Denis S. Kutilin
Publikováno v:
Molecular Biology. 54:520-534
Autor:
Denis S. Kutilin, Vladimir Trifanov, Nataliya N. Timoshkina, Nataliya A. Petrusenko, Dmitry Yu. Gvaldin, Oleg I. Kit
Publikováno v:
Molecular Biology Reports. 47:4233-4243
Despite advances in classification, treatment, and imaging, neuroendocrine tumours remain a clinically complex subject. In this work, we studied the genetic profile of well-differentiated pancreatic neuroendocrine tumours (PanNETs) in a cohort of Cau
Publikováno v:
Problems in oncology. 65:691-700
Esophageal squamous cell carcinoma (ESCC) is a group of heterogeneous tumors with a different prognosis. In recent years, various molecular signatures of ESCC have been identified, which are different in different populations. The aim of the study wa
Autor:
Denis S. Kutilin, Mikhail S. Zinkovich, Marina A. Gusareva, Aleksey N. Shevchenko, Aleksandr V. Faenson, Anna A. Solntseva, Natalya B. Fatkina, Ekaterina O. Vasilieva, Elena V. Filatova, Natalia G Kosheleva, Ekaterina A. Tolmacheva, Ksenia V. Martynova, Madina A. Gappoeva, Irina A. Udalenkova, Irina A. Khomutenko, Lyudmila Ya Rozenko, Inna V. Pavlyatenko, Astanda K. Gvaramiya, Oleg I. Kit
Publikováno v:
Journal of Clinical Oncology. 40:e17008-e17008
e17008 Background: Radiotherapy (RT) is one of the main treatments for prostate cancer (PC). The effectiveness of RT depends on the initial radioresistance of tumor cells provided by their certain molecular features - the transcriptional activity of
Autor:
Natalya N. Timoshkina, Natalia A. Petrusenko, Al-Nsour Rashed, Astanda K. Gvaramiya, Madina A. Gappoeva, Dmitriy A. Savchenko, Oleg I. Kit, Denis S. Kutilin
Publikováno v:
Journal of Clinical Oncology. 40:e20514-e20514
e20514 Background: Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers and remains the most commonly diagnosed human neoplasm with a poor prognosis. Significantly improving the clinical course of NSCLC, EGFR tyrosine kinase inhibi
Autor:
Natalia N. Tsaplina, Natalya V. Porkhanova, Natalya B. Fatkina, Mikhail S. Zinkovich, Marina A. Gusareva, Anna A. Solntseva, Ekaterina O. Vasilieva, Natalia G Kosheleva, Ekaterina A. Tolmacheva, Ksenia V. Martynova, Irina A. Udalenkova, Lyudmila Ya Rozenko, Olga G. Selezneva, Alla V. Pustovalova, Tatiana G. Chalabova, Olga V. Shlyakhova, Pavel N. Meshcheryakov, Sergey V. Oskin, Oleg I. Kit, Denis S. Kutilin
Publikováno v:
Journal of Clinical Oncology. 40:e17512-e17512
e17512 Background: Cervical cancer (CC) is one of the most common cancers in women worldwide (4th in frequency). Traditionally, radical hysterectomy or radiation therapy (RT) is used as the standard treatment for early-stage CC, and locally advanced
Autor:
Natalya N. Timoshkina, Natalia A. Petrusenko, Dmitry Yu. Gvaldin, Madina A. Gappoeva, Sergey E. Kavitskiy, Maria A. Cherkes, Ekaterina V. Verenikina, Denis S. Kutilin
Publikováno v:
Journal of Clinical Oncology. 40:e17548-e17548
e17548 Background: About 10-15% of malignant ovarian tumors (OC) are associated with hereditary diseases, and about 65-85% of hereditary OC have a mutation in BRCA1/2 genes. The aim of the study was to analyze BRCA1/2 genes hereditary mutation spectr